Shanxi Qianyecao Biotech QYC
Finnrick has tested 125 samples from Shanxi Qianyecao Biotech QYC across 9 products.
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Cagrilintide | 5 | 2 Feb 2026 | 17 Jul 2026 | |||||
| TB-500 | 4 | 25 Nov 2025 | 17 Jul 2026 | |||||
| Ipamorelin | 5 | 25 Nov 2025 | 5 Aug 2026 | |||||
| NAD+ | 4 | 6 Mar 2026 | 4 Aug 2026 | |||||
| Tirzepatide | 22 | 11 Jun 2025 | 21 Jul 2026 | |||||
| BPC-157 | 8 | 14 Nov 2025 | 23 Jul 2026 | |||||
| GHK-Cu | 13 | 25 Sep 2025 | 9 Aug 2026 | |||||
| Retatrutide | 52 | 24 Jul 2025 | 5 Aug 2026 | |||||
| Tesamorelin | 12 | 17 Nov 2025 | 21 Jul 2026 | |||||
The Shanxi Qianyecao Biotech QYC samples tested by Finnrick were either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
Based on 50 overall satisfaction reports
People who submitted test requests to Finnrick gave Shanxi Qianyecao Biotech QYC an average satisfaction rating of 4.2 out of 5 across 50 reports associated with samples received and tested by Finnrick.
Most recent Shanxi Qianyecao Biotech QYC tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 9 Aug 2026 | GHK-Cu | View | 50mg | 53.3mg | +6.6% | 99.70% | n/a | QY-0286-CU50 | Silver label / Silver crimp / Clear Blue cap | Lab G | Public | |
| 5 Aug 2026 | Retatrutide | View | 5mg | 4.89mg | -2.2% | 69.60% | n/a | QY-9619-RT5 | Silver label / Silver crimp / Blue cap | Lab E | Public | |
| 5 Aug 2026 | Ipamorelin | View | 5mg | 7.31mg | +46.2% | 97.10% | n/a | QY-9092-IPA5 | Silver label / Silver crimp / Blue cap | Lab E | Public | |
| 4 Aug 2026 | Retatrutide | View | 20mg | ⚠️ Sample does not contain Retatrutide | not detected | RT20SD062026 | No label / Silver crimp / Blue cap | Lab E | Public | |||
| 4 Aug 2026 | NAD+ | View | 500mg | 453mg | -9.4% | 88.50% | low | NAD50SD062026 | No label / Silver crimp / Blue cap | Lab E | Public | |
| 23 Jul 2026 | BPC-157 | View | 5mg | 5.08mg | +1.6% | 99.90% | n/a | QY-3168-BC5 | Silver label / Silver crimp / Yellow cap | Lab E | Public | |
| 21 Jul 2026 | Tirzepatide | View | 5mg | 4.29mg | -14.2% | 99.90% | n/a | QY-9325-TR5 | Silver label / Silver crimp / Black cap | Lab E | Public | |
Corrections
- 17 Aug 2026: NAD+
- The requester submitted the NAD+ sample with a declared potency of 50 mg. The correct potency is 500 mg. The recorded data has been corrected to reflect the accurate potency of 500 mg.
About Shanxi Qianyecao Biotech QYC Test Results From Finnrick
Shanxi Qianyecao Biotech QYC is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 9 products and 125 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud) and customer satisfaction reports with sub-scores that provide additional context. Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
Shanxi Qianyecao Biotech QYC Testing Activity & Score Summary
In the past 30 days, Finnrick has published 5 new test results for Shanxi Qianyecao Biotech QYC, and 11 in the past three months. The overall dataset includes 125 tested samples with an average score of 6.8/10 across all products.
Across 125 identity-tested samples, 97% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.8%. Approximately 89% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 3):
- Retatrutide (52 tests, 96% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 0.0 to 10.0 (average 7.0/10), suggesting significant batch-to-batch differences.
- Tesamorelin (12 tests, 100% identity pass, median purity 99.7%) — Test scores are highly variable, ranging from 2.6 to 10.0 (average 6.4/10), suggesting significant batch-to-batch differences.
- Tirzepatide (22 tests, 100% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 3.5 to 8.0 (average 6.7/10), suggesting significant batch-to-batch differences.